Nanomaterial-Based Drug Delivery Systems Therapeutic and Theranostic Applications /

Effective drug delivery systems are essential in maximizing the therapeutic effects of the drugs in question. This book thoroughly analyses recent technological advances in new, nanomaterial-based drug delivery systems for the diagnosis and treatment of various diseases. These systems also have dive...

詳細記述

保存先:
書誌詳細
団体著者: SpringerLink (Online service)
その他の著者: Pardeshi, Chandrakantsing V. (編集者)
フォーマット: 電子媒体 eBook
言語:英語
出版事項: Cham : Springer International Publishing : Imprint: Springer, 2023.
版:1st ed. 2023.
主題:
オンライン・アクセス:https://doi.org/10.1007/978-3-031-30529-0
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

MARC

LEADER 00000nam a22000005i 4500
001 978-3-031-30529-0
003 DE-He213
005 20260810170922.0
007 cr nn 008mamaa
008 230621s2023 sz | o |||| 0|eng d
020 |a 9783031305290  |9 978-3-031-30529-0 
024 7 |a 10.1007/978-3-031-30529-0  |2 doi 
050 4 |a RS400-431 
072 7 |a PSB  |2 bicssc 
072 7 |a SCI013040  |2 bisacsh 
072 7 |a PNB  |2 thema 
082 0 4 |a 615.19  |2 23 
245 1 0 |a Nanomaterial-Based Drug Delivery Systems  |h [electronic resource] :  |b Therapeutic and Theranostic Applications /  |c edited by Chandrakantsing V. Pardeshi. 
250 |a 1st ed. 2023. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2023. 
300 |a 1 online resource (XII, 409 p. 100 illus.).  |b 97 illus. in color. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
341 0 |b Table of contents navigation  |2 onix 
341 0 |b Single logical reading order  |2 onix 
341 0 |b Short alternative textual descriptions  |2 onix 
341 0 |b Use of color is not sole means of conveying information  |2 onix 
341 0 |b Use of high contrast between text and background color  |2 onix 
341 0 |b Next / Previous structural navigation  |2 onix 
341 0 |b All non-decorative content supports reading without sight  |2 onix 
347 |a text file  |b PDF  |2 rda 
505 0 |a Section-I: Introduction to nanomaterials for drug delivery -- Introduction to Nanomaterials for drug delivery -- Section-II: Nanomaterials-based drug delivery systems for Therapeutic applications -- Polymer-based nanomaterials -- Lipid-based nanomaterials -- Vesicular nanomaterials -- Hybrid nanomaterials -- Section-III: Nanomaterials-based drug delivery systems for Theranostic applications -- Magnetic nanoparticles -- Quantum dots -- Upconversion nanoparticles -- Gold nanoparticles -- Carbon-based nanoparticles -- Graphene-based nanoparticles -- Section-IV: Nanomaterials toxicity & clinical translation -- Nanotoxicology: an overview -- Patenting nanomaterials: Regulatory aspects -- Clinical perspectives: Translating nanomaterials from laboratory to clinic. 
520 |a Effective drug delivery systems are essential in maximizing the therapeutic effects of the drugs in question. This book thoroughly analyses recent technological advances in new, nanomaterial-based drug delivery systems for the diagnosis and treatment of various diseases. These systems also have diverse applications in pharmaceutical, biomedical, biomaterial, and biotechnological fields. This book explains the different types of nanocarriers currently in development and covers both therapeutic and theranostic applications of drug-loaded nanocarriers and nanomedicine. Clinical research professionals, industrial pharmaceutical scientists, and veteran drug delivery developers benefit from the unique structure of this book, making it essential for the drug delivery researcher. Students, research scholars, and industrial professionals alike benefit from the current technological advancements, regulatory aspects, and the history of discovery and development in the field of nanomedicine presented in this book. 
532 8 |a Accessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. 
532 8 |a No reading system accessibility options actively disabled 
532 8 |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com 
588 |a Print version record. 
650 0 |a Pharmaceutical chemistry. 
650 0 |a Nanomedicine. 
650 0 |a Toxicology. 
650 0 |a Pharmacology. 
650 1 4 |a Pharmaceutics. 
650 2 4 |a Nanomedicine and Nanotoxicology. 
650 2 4 |a Toxicology. 
650 2 4 |a Pharmacology. 
650 2 4 |a Medical Toxicology. 
700 1 |a Pardeshi, Chandrakantsing V.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783031305283 
776 0 8 |i Printed edition:  |z 9783031305306 
776 0 8 |i Printed edition:  |z 9783031305313 
856 4 0 |u https://doi.org/10.1007/978-3-031-30529-0 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)